Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole dose reduction maintenance trial in eosinophilic oesophagitis
ACTRN12625001297415Phase 4Not yet recruiting
- Sponsor
- Northern Adelaide Local Health Network
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pantoprazole in eosinophilic esophagitis (EoE) (2 arms), sponsored by Northern Adelaide Local Health Network. Primary endpoint: Peak eosinophil count at follow-up endoscopy and biopsy. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
pantoprazole
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on ACTRN12625001297415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001297415.